Fulvio Massaro - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Fulvio Massaro

This paper is made freely available by the publisher.

2022 Fulvio Massaro

ORCID

, Nathalie Meuleman, Dominique Bron, Marie Vercruyssen

ORCID

, Marie Maerevoet

Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2021 Fulvio Massaro

ORCID

, Vincenzo Pavone, Piero Maria Stefani, Barbara Botto, Alessandro Pulsoni, Caterina Patti, Maria Cantonetti, Andrea Visentin

ORCID

, Potito Rosario Scalzulli, Andrea Rossi, Sara Galimberti, Michele Cimminiello, Guido Gini, Maurizio Musso, Marco Sorio and 14 other authors

Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience

Upload

This paper is made freely available by the publisher.

2020 Fulvio Massaro

ORCID

, Florent Corrillon, Basile Stamatopoulos, Nathalie Meuleman, Laurence Lagneaux, Dominique Bron

Aging of Bone Marrow Mesenchymal Stromal Cells: Hematopoiesis Disturbances and Potential Role in the Development of Hematologic Cancers

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Fulvio Massaro

ORCID

, Yana Stepanishyna, Martina Manni

ORCID

, Stefano Luminari, Sara Galimberti, Luigi Marcheselli, Carlo Visco

ORCID

, Cristina Tecchio, Caterina Stelitano, Francesco Angrilli, Mario Petrini, Francesco Merli, Massimo Federico

Long‐term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high‐dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma

Upload

Missing publications? Search for publications with a matching author name.